{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T05:54:01Z","timestamp":1777874041606,"version":"3.51.4"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/R005850\/1"],"award-info":[{"award-number":["MR\/R005850\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004901","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de Minas Gerais","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbial Pathogenesis"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.micpath.2021.104745","type":"journal-article","created":{"date-parts":[[2021,1,21]],"date-time":"2021-01-21T22:26:41Z","timestamp":1611268001000},"page":"104745","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Leishmania eukaryotic elongation Factor-1 beta protein is immunogenic and induces parasitological protection in mice against Leishmania infantum infection"],"prefix":"10.1016","volume":"151","author":[{"given":"Tha\u00eds T.O.","family":"Santos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda S.","family":"Machado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernanda F.","family":"Ramos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo\u00e3o A.","family":"Oliveira-da-Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela P.","family":"Lage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grasiele S.V.","family":"Tavares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D\u00e9bora V.C.","family":"Mendon\u00e7a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4351-5835","authenticated-orcid":false,"given":"Mariana S.","family":"Cardoso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Williane F.","family":"Siqueira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V\u00edvian T.","family":"Martins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernanda","family":"Ludolf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thiago A.R.","family":"Reis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L\u00edvia M.","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7882-215X","authenticated-orcid":false,"given":"Camila S.","family":"Freitas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raquel S.","family":"Bandeira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra M.","family":"Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jamil S.","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricardo L.F.","family":"Moreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricardo T.","family":"Fujiwara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno M.","family":"Roatt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel A.","family":"Ch\u00e1vez-Fumagalli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5728-6981","authenticated-orcid":false,"given":"Maria V.","family":"Humbert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ant\u00f4nio L.","family":"Teixeira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo A.F.","family":"Coelho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.micpath.2021.104745_bib1","author":"World Health Organization"},{"key":"10.1016\/j.micpath.2021.104745_bib2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0035671","article-title":"Leishmaniasis worldwide and global estimates of its incidence","volume":"7","author":"Alvar","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.micpath.2021.104745_bib3","first-page":"98","article-title":"Recent developments and future prospects in the treatment of visceral leishmaniasis","volume":"3","author":"Sundar","year":"2016","journal-title":"Ther Adv Infect Dis"},{"key":"10.1016\/j.micpath.2021.104745_bib4","doi-asserted-by":"crossref","first-page":"967","DOI":"10.2741\/4629","article-title":"Leishmaniasis treatment: update of possibilities for drug repurposing","volume":"23","author":"Andrade-Neto","year":"2018","journal-title":"Frontiers in Bioscience (Landmark Ed)"},{"key":"10.1016\/j.micpath.2021.104745_bib5","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1111\/j.1462-5822.2008.01146.x","article-title":"Mechanisms and consequences of persistence of intracellular pathogens: leishmaniasis as an example","volume":"10","author":"Bogdan","year":"2008","journal-title":"Cell Microbiol."},{"key":"10.1016\/j.micpath.2021.104745_bib6","first-page":"1","article-title":"Immune responses during cutaneous and visceral leishmaniasis","volume":"30","author":"Kedzierski","year":"2014","journal-title":"Parasitology"},{"key":"10.1016\/j.micpath.2021.104745_bib7","doi-asserted-by":"crossref","first-page":"684","DOI":"10.3389\/fimmu.2017.00684","volume":"8","author":"Athanasiou","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.micpath.2021.104745_bib8","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s13071-016-1412-x","article-title":"Regulation of immunity during visceral Leishmania infection","volume":"9","author":"Rodrigues","year":"2016","journal-title":"Parasites Vectors"},{"key":"10.1016\/j.micpath.2021.104745_bib9","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1111\/pim.12287","article-title":"Prophylactic properties of a Leishmania-specific hypothetical protein in a murine model of visceral leishmaniasis","volume":"37","author":"Lage","year":"2015","journal-title":"Parasite Immunol."},{"key":"10.1016\/j.micpath.2021.104745_bib10","doi-asserted-by":"crossref","first-page":"6169","DOI":"10.2147\/IJN.S141069","article-title":"Vaccination with poly(D,L-lactide-cog-lycolide) nanoparticles loaded with soluble Leishmania antigens and modified with a TNFalpha-mimicking peptide or monophosphoryl lipid A confers protection against experimental visceral leishmaniasis","volume":"12","author":"Margaroni","year":"2017","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.micpath.2021.104745_bib11","doi-asserted-by":"crossref","DOI":"10.1111\/pim.12359","article-title":"A recombinant chimeric protein composed of human and mice-specific CD4+ and CD8+ T-cell epitopes protects against visceral leishmaniasis","volume":"39","author":"Martins","year":"2017","journal-title":"Parasite Immunol."},{"key":"10.1016\/j.micpath.2021.104745_bib12","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.molimm.2018.08.004","article-title":"Induction of protective cellular immune responses against experimental visceral leishmaniasis mediated by dendritic cells pulsed with the N-terminal domain of Leishmania infantum elongation factor-2 and CpG oligodeoxynucleotides","volume":"103","author":"Agallou","year":"2018","journal-title":"Mol. Immunol."},{"issue":"22","key":"10.1016\/j.micpath.2021.104745_bib13","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1016\/j.vaccine.2004.11.061","article-title":"Protection against experimental visceral leishmaniasis infection in dogs immunized with purified excreted secreted antigens of Leishmania infantum promastigotes","volume":"23","author":"Lemesre","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.micpath.2021.104745_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0185438","article-title":"Field trial of efficacy of the Leish-Tec\u00ae vaccine against canine leishmaniasis caused by Leishmania infantum in an endemic area with high transmission rates","volume":"12","author":"Grimaldi","year":"2017","journal-title":"PloS One"},{"key":"10.1016\/j.micpath.2021.104745_bib15","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.molimm.2017.02.008","article-title":"Inflammatory chemokines and their receptors in human visceral leishmaniasis: gene expression profile in peripheral blood, splenic cellular sources and their impact on trafficking of inflammatory cells","volume":"85","author":"Singh","year":"2017","journal-title":"Mol. Immunol."},{"issue":"22","key":"10.1016\/j.micpath.2021.104745_bib16","doi-asserted-by":"crossref","first-page":"4863","DOI":"10.1016\/j.vaccine.2006.03.005","article-title":"Immunotherapy against visceral leishmaniasis with the nucleoside hydrolase-DNA vaccine of Leishmania donovani","volume":"24","author":"Gamboa-Le\u00f3n","year":"2006","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.micpath.2021.104745_bib17","doi-asserted-by":"crossref","first-page":"304","DOI":"10.7555\/JBR.30.20150125","article-title":"Immunogenicity and protective efficacy of DNA vaccine against visceral leishmaniasis in BALB\/c mice","volume":"30","author":"Kaur","year":"2016","journal-title":"J Biomed Res"},{"issue":"1","key":"10.1016\/j.micpath.2021.104745_bib18","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/imm.13007","article-title":"DNA prime-protein boost vaccine encoding HLA-A2, HLA-A24 and HLA-DR1 restricted epitopes of CaNA2 against visceral leishmaniasis","volume":"156","author":"He","year":"2019","journal-title":"Immunology"},{"issue":"5","key":"10.1016\/j.micpath.2021.104745_bib19","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/pim.12315","article-title":"DNA vaccine against visceral leishmaniasis: a promising approach for prevention and control","volume":"38","author":"Kumar","year":"2016","journal-title":"Parasite Immunol."},{"issue":"4","key":"10.1016\/j.micpath.2021.104745_bib20","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.bbrc.2007.03.077","article-title":"Molecular architecture of Leishmania EF-1alpha reveals a novel site that may modulate protein translation: a possible target for drug development","volume":"356","author":"Lopez","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"12","key":"10.1016\/j.micpath.2021.104745_bib21","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1089\/vbz.2018.2347","article-title":"Cloning and recombinant expression of elongation factor-1\u03b1 of Leishmania mexicana","volume":"18","author":"L\u00f3pez-L\u00f3pez","year":"2018","journal-title":"Vector Borne Zoonotic Dis."},{"key":"10.1016\/j.micpath.2021.104745_bib22","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.bbrc.2007.03.077","article-title":"Molecular architecture of leishmania EF-1alpha reveals a novel site that may modulate protein translation: a possible target for drug development","volume":"356","author":"Lopez","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.micpath.2021.104745_bib23","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1002\/pmic.200600725","article-title":"Proteomic approach for identification and characterization of novel immunostimulatory proteins from soluble antigens of Leishmania donovani promastigotes","volume":"7","author":"Gupta","year":"2007","journal-title":"Proteomics"},{"key":"10.1016\/j.micpath.2021.104745_bib24","first-page":"1","article-title":"Screening diagnostic candidates from Leishmania infantum proteins for human visceral leishmaniasis using an immunoproteomics approach","author":"Lage","year":"2019","journal-title":"Parasitology"},{"key":"10.1016\/j.micpath.2021.104745_bib25","doi-asserted-by":"crossref","first-page":"103783","DOI":"10.1016\/j.micpath.2019.103783","article-title":"Recombinant Leishmania eukaryotic elongation factor-1 beta protein: a potential diagnostic antigen to detect tegumentary and visceral leishmaniasis in dogs and humans","volume":"137","author":"Santos","year":"2019","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.micpath.2021.104745_bib26","doi-asserted-by":"crossref","first-page":"3988","DOI":"10.1128\/IAI.71.7.3988-3994.2003","article-title":"Immune responses induced by the Leishmania (Leishmania) donovani A2 antigen, but not by the LACK antigen, are protective against experimental Leishmania (Leishmania) amazonensis infection","volume":"71","author":"Coelho","year":"2003","journal-title":"Infect. Immun."},{"key":"10.1016\/j.micpath.2021.104745_bib27","doi-asserted-by":"crossref","first-page":"8240784","DOI":"10.1155\/2019\/8240784","article-title":"Development and clinical evaluation of Loop-mediated isothermal amplification (LAMP) assay for the diagnosis of human visceral leishmaniasis in Brazil","volume":"2019","author":"Avelar","year":"2019","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.micpath.2021.104745_bib28","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.trsl.2018.05.001","article-title":"Vaccination with a CD4(+) and CD8(+) T-cell epitopes-based recombinant chimeric protein derived from Leishmania infantum proteins confers protective immunity against visceral leishmaniasis","volume":"200","author":"Dias","year":"2018","journal-title":"Transl. Res."},{"key":"10.1016\/j.micpath.2021.104745_bib29","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1128\/MCB.01270-12","article-title":"Phosphorylation of eukaryotic elongation factor 2 (eEF2) by cyclin A-cyclin-dependent kinase 2 regulates its inhibition by eEF2 kinase","volume":"33","author":"Hizli","year":"2013","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.micpath.2021.104745_bib30","doi-asserted-by":"crossref","first-page":"404","DOI":"10.7150\/ijms.8033","article-title":"All human EF1\u03b1 promoters are not equal: markedly affect gene expression in constructs from different sources","volume":"11","author":"Zheng","year":"2014","journal-title":"Int. J. Med. Sci."},{"issue":"12","key":"10.1016\/j.micpath.2021.104745_bib31","doi-asserted-by":"crossref","first-page":"E2094","DOI":"10.3390\/molecules22122094","article-title":"The eukaryotic elongation factor 1 alpha (eEF1\u03b1) from the parasite leishmania infantum is modified with the immunomodulatory substituent phosphorylcholine (PC)","volume":"22","author":"Timm","year":"2017","journal-title":"Molecules"},{"issue":"12","key":"10.1016\/j.micpath.2021.104745_bib32","doi-asserted-by":"crossref","first-page":"6417","DOI":"10.4049\/jimmunol.1102081","article-title":"Elongation factor-2, a Th1 stimulatory protein of Leishmania donovani, generates strong IFN-\u03b3 and IL-12 response in cured Leishmania-infected patients\/hamsters and protects hamsters against Leishmania challenge","volume":"187","author":"Kushawaha","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.micpath.2021.104745_bib33","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.molimm.2018.08.004","article-title":"Induction of protective cellular immune responses against experimental visceral leishmaniasis mediated by dendritic cells pulsed with the N-terminal domain of Leishmania infantum elongation factor-2 and CpG oligodeoxynucleotides","volume":"103","author":"Agallou","year":"2018","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.micpath.2021.104745_bib34","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3389\/fimmu.2018.00018","article-title":"Liposomal elongation factor-1\u03b1 triggers effector CD4 and CD8 T cells for induction of long-lasting protective immunity against visceral leishmaniasis","volume":"9","author":"Sabur","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.micpath.2021.104745_bib35","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.molimm.2018.12.025","article-title":"Immunogenicity and protective efficacy of a new Leishmania hypothetical protein applied as a DNA vaccine or in a recombinant form against Leishmania infantum infection","volume":"106","author":"Ribeiro","year":"2019","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.micpath.2021.104745_bib36","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.molimm.2020.06.010","article-title":"Leishmania infantum pyridoxal kinase evaluated in a recombinant protein and DNA vaccine to protects against visceral leishmaniasis","volume":"124","author":"Oliveira-da-Silva","year":"2020","journal-title":"Mol. Immunol."},{"issue":"3","key":"10.1016\/j.micpath.2021.104745_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0230381","article-title":"The immunogenicity and protective immunity of multi-epitopes DNA prime-protein boost vaccines encoding Amastin-Kmp-11, Kmp11-Gp63 and Amastin-Gp63 against visceral leishmaniasis","volume":"15","author":"Zhang","year":"2020","journal-title":"PloS One"},{"key":"10.1016\/j.micpath.2021.104745_bib38","doi-asserted-by":"crossref","first-page":"112","DOI":"10.3389\/fcimb.2018.00112","article-title":"Analysis of the antigenic and prophylactic properties of the leishmania translation initiation factors eIF2 and eIF2B in natural and experimental leishmaniasis","volume":"8","author":"Garde","year":"2018","journal-title":"Front Cell Infect Microbiol"},{"issue":"37","key":"10.1016\/j.micpath.2021.104745_bib39","doi-asserted-by":"crossref","first-page":"4813","DOI":"10.1016\/j.vaccine.2008.06.102","article-title":"Induction of Th1-type cellular responses in cured\/exposed Leishmania-infected patients and hamsters against polyproteins of soluble Leishmania donovani promastigotes ranging from 89.9 to 97.1 kDa","volume":"26","author":"Kumari","year":"2008","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.micpath.2021.104745_bib40","doi-asserted-by":"crossref","first-page":"6417","DOI":"10.4049\/jimmunol.1102081","article-title":"Elongation factor-2, a Th1 stimulatory protein of Leishmania donovani, generates strong IFN-\u03b3 and IL-12 response in cured Leishmania-infected patients\/hamsters and protects hamsters against Leishmania challenge","volume":"187","author":"Kushawaha","year":"2011","journal-title":"J. Immunol."},{"issue":"16","key":"10.1016\/j.micpath.2021.104745_bib41","doi-asserted-by":"crossref","first-page":"832","DOI":"10.6026\/97320630009832","article-title":"A comprehensive analysis of LACK (Leishmania homologue of receptors for activated C kinase) in the context of Visceral Leishmaniasis","volume":"9","author":"Sinha","year":"2013","journal-title":"Bioinformation"},{"issue":"4","key":"10.1016\/j.micpath.2021.104745_bib42","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1021\/pr400923g","article-title":"Identification of virulence factors in Leishmania infantum strains by a proteomic approach","volume":"13","author":"Pires","year":"2014","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.micpath.2021.104745_bib43","doi-asserted-by":"crossref","first-page":"524","DOI":"10.3389\/fimmu.2015.00524","article-title":"Kinetoplastid membrane protein-11 as a vaccine candidate and a virulence factor in leishmania","volume":"6","author":"Mendon\u00e7a","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.micpath.2021.104745_bib44","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1590\/0037-8682-0120-2016","article-title":"Recent updates and perspectives on approaches for the development of vaccines against visceral leishmaniasis","volume":"49","author":"Duarte","year":"2016","journal-title":"Rev. Soc. Bras. Med. Trop."},{"key":"10.1016\/j.micpath.2021.104745_bib45","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.vetpar.2016.07.011","article-title":"Current status on prevention and treatment of canine leishmaniasis","volume":"227","author":"Reguera","year":"2016","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.micpath.2021.104745_bib46","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.molimm.2016.12.022","article-title":"Immunization with Leishmania donovani protein disulfide isomerase DNA construct induces Th1 and Th17 dependent immune response and protection against experimental visceral leishmaniasis in Balb\/c mice","volume":"82","author":"Amit","year":"2017","journal-title":"Mol. Immunol."},{"issue":"9","key":"10.1016\/j.micpath.2021.104745_bib47","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0108556","article-title":"Th1 stimulatory proteins of Leishmania donovani: comparative cellular and protective responses of rTriose phosphate isomerase, rProtein disulfide isomerase and rElongation factor-2 in combination with rHSP70 against visceral leishmaniasis","volume":"9","author":"Jaiswal","year":"2014","journal-title":"PloS One"},{"issue":"3","key":"10.1016\/j.micpath.2021.104745_bib48","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1007\/s00436-013-3716-5","article-title":"Efficacy of Leishmania donovani trypanothione reductase, identified as a potent Th1 stimulatory protein, for its immunogenicity and prophylactic potential against experimental visceral leishmaniasis","volume":"113","author":"Khare","year":"2014","journal-title":"Parasitol. Res."},{"issue":"6","key":"10.1016\/j.micpath.2021.104745_bib49","doi-asserted-by":"crossref","first-page":"667","DOI":"10.2174\/1566524043360203","article-title":"Leishmaniasis: current status of vaccine development","volume":"4","author":"Sukumaran","year":"2004","journal-title":"Curr. Mol. Med."},{"issue":"4","key":"10.1016\/j.micpath.2021.104745_bib50","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.mib.2012.05.002","article-title":"Making an anti-amastigote vaccine for visceral leishmaniasis: rational, update and perspectives","volume":"15","author":"Fernandes","year":"2012","journal-title":"Curr. Opin. Microbiol."},{"key":"10.1016\/j.micpath.2021.104745_bib51","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.vetpar.2015.07.005","article-title":"Immunological comparison of DNA vaccination using two delivery systems against canine leishmaniasis","volume":"212","author":"Shahbazi","year":"2015","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.micpath.2021.104745_bib52","doi-asserted-by":"crossref","first-page":"304","DOI":"10.7555\/JBR.30.20150125","article-title":"Immunogenicity and protective efficacy of DNA vaccine against visceral leishmaniasis in BALB\/c mice","volume":"30","author":"Kaur","year":"2016","journal-title":"J. Biomed. Res."},{"key":"10.1016\/j.micpath.2021.104745_bib53","doi-asserted-by":"crossref","first-page":"9124326","DOI":"10.1155\/2019\/9124326","article-title":"New insights on the adjuvant properties of the Leishmania infantum eukaryotic initiation factor","volume":"2019","author":"Koutsoni","year":"2019","journal-title":"J Immunol Res"},{"key":"10.1016\/j.micpath.2021.104745_bib54","doi-asserted-by":"crossref","first-page":"380","DOI":"10.3389\/fimmu.2014.00380","article-title":"Visceral leishmaniasis: advancements in vaccine development via classical and molecular approaches","volume":"5","author":"Joshi","year":"2014","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.micpath.2021.104745_bib55","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.micinf.2017.03.002","article-title":"Bimal Immuno-informatics based approaches to identify CD8+ T cell epitopes within the Leishmania donovani 3-ectonucleotidase in cured visceral leishmaniasis subjects","volume":"19","author":"Vijayamahantesh","year":"2017","journal-title":"S.Microbes Infect."},{"key":"10.1016\/j.micpath.2021.104745_bib56","doi-asserted-by":"crossref","first-page":"381","DOI":"10.3389\/fcimb.2018.00381","article-title":"Cellular markers of active disease and cure in different forms of leishmania infantum-induced disease","volume":"8","author":"Botana","year":"2018","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.micpath.2021.104745_bib57","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1365-3083.2005.01686.x","article-title":"Immune response in human visceral leishmaniasis: analysis of the correlation between innate immunity cytokine profile and disease outcome","volume":"62","author":"Peruhype-Magalh\u00e3es","year":"2005","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.micpath.2021.104745_bib58","doi-asserted-by":"crossref","first-page":"155031","DOI":"10.1016\/j.cyto.2020.155031","article-title":"Leishmania infantum amastin protein incorporated in distinct adjuvant systems induces protection against visceral leishmaniasis","volume":"129","author":"Ribeiro","year":"2020","journal-title":"Cytokine"}],"container-title":["Microbial Pathogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401021000176?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401021000176?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T18:52:11Z","timestamp":1777575131000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0882401021000176"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":58,"alternative-id":["S0882401021000176"],"URL":"https:\/\/doi.org\/10.1016\/j.micpath.2021.104745","relation":{},"ISSN":["0882-4010"],"issn-type":[{"value":"0882-4010","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Leishmania eukaryotic elongation Factor-1 beta protein is immunogenic and induces parasitological protection in mice against Leishmania infantum infection","name":"articletitle","label":"Article Title"},{"value":"Microbial Pathogenesis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micpath.2021.104745","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104745"}}